Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

27
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
27
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.6K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.3K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.3K
Subviral Agents01:29

Subviral Agents

814
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
814
Retroviruses02:33

Retroviruses

15.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.9K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of Tumor-Immune Cell Communications via Enantioselectively Targeting SLC G-Quadruplexes.

Journal of the American Chemical Society·2026
Same author

Scaling covalent ligand discovery through dynamic combinatorial library-versus-proteome screening.

Nature communications·2026
Same author

Neuron-targeting piezoelectric microneedles disrupt pro-tumorigenic neuron-immune crosstalk and restore anti-tumor immunity in melanoma.

Nature communications·2026
Same author

Comparative Interactome Profiling of Itaconate and α-Ketoglutarate by the Peptide-Centric Local Stability Assay.

ACS chemical biology·2026
Same author

Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value.

Clinical and experimental medicine·2026
Same author

Ligand-modulated metal-radical polarity match enables general 1,2-dicarbofunctionalization of ethylene.

Nature chemistry·2026

Related Experiment Video

Updated: Apr 2, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

20.0K

Nucleoside-ATTEC Conjugates for Targeting Inhibition of HIV Replication and Infection.

Xiaofeng Liao1,2, Kaifu Zhang3, Chu Wang3

  • 1Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.

Journal of Medicinal Chemistry
|April 1, 2026
PubMed
Summary
This summary is machine-generated.

A novel nucleoside-autophagosome-tethering compound (ATTEC) targets HIV-1 by degrading viral DNA. This approach offers prolonged inhibition of HIV replication and infection without affecting cell growth.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.9K

Related Experiment Videos

Last Updated: Apr 2, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

20.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.9K

Area of Science:

  • Biochemistry
  • Virology
  • Drug Discovery

Background:

  • HIV-1 reverse transcriptase (RT) is a crucial target for antiretroviral therapy.
  • Current RT inhibitors cannot eliminate proviral DNA and face challenges with drug resistance.
  • A new strategy is needed to overcome limitations of existing HIV treatments.

Purpose of the Study:

  • To develop a novel nucleoside-autophagosome-tethering compound (ATTEC) for HIV-1 inhibition.
  • To induce degradation of viral cDNA during HIV replication.
  • To create a potent and long-lasting HIV therapeutic strategy.

Main Methods:

  • Synthesized 5,7-dihydroxy-4-phenylcoumarin (DP) derivatives as LC3-binding ligands.
  • Conjugated DP derivatives with 3'-azidothymidine (AZT) via click chemistry to form nucleoside-ATTECs.
  • Optimized linker length and evaluated the efficacy of nucleoside-ATTECs in human cells.

Main Results:

  • Developed nucleoside-ATTECs effectively inhibit HIV-1 replication and infection in human cells.
  • The compounds demonstrated no adverse effects on cell proliferation.
  • Optimized DP-AZT showed prolonged inhibition of HIV-1 replication.

Conclusions:

  • Nucleoside-ATTECs represent a promising new approach for HIV-1 inhibition.
  • This strategy targets viral cDNA degradation, offering an advantage over traditional RT inhibitors.
  • The developed ATTEC approach provides a potential platform for novel HIV therapeutics.